Your World Biomarkers & Diagnostics Event Series Schedule
Since 2010, the World Biomarkers & Diagnostics Event Series has been at the centre of the precision medicine community; uniting thought leaders and innovators across biomarker operations, solid tissue and liquid biopsy companion diagnostics, AI-enabled platforms and multimodal data, biomarker testing and IVD regulation.
Providing a much-needed platform for candid conversations on how to discover, validate, and translate meaningful biomarkers and diagnostic tools from bench-to-bedside, the series supports teams working to improve decision-making across the entire drug and device co-development lifecycle. Whether you are advancing early discovery biomarkers, designing next generation IVD trials, evaluating new diagnostic partners or enabling precision-guided therapies, this highly focused event series is dedicated to helping the right drug, reach the right patient, at the right time.
As pharma, biotech, diagnostic, technology and testing lab providers strive to develop more effective, scalable and equitable testing solutions for patients, join our global industry-leading meetings to share real-world experiences, compare emerging evidence, and accelerate the adoption of clinically impactful biomarker and diagnostic innovations in oncology and beyond.
Explore the Agenda
Gain first-hand insights into the latest translational, clinical and commercial strides shaping biomarker-led trials and CDx approvals. From IVDR, to the COMBINE pilot, explore Europe’s most innovative precision medicine advances through a packed agenda of expert-led sessions and exclusive Rx-Dx partnership discussions
Partner With Us
Position your brand alongside leading global and European-local IVD innovators, clinical and biosample management leaders and laboratory service to stay of the pinnacle of bringing precision therapeutics from bench-to-bedside
Join Biopharma Experts
Join Europe’s most comprehensive and trusted senior precision medicine community for dynamic and high-impact conversations across diverse precision medicine therapy areas, modalities, biosample types and testing platforms